10 Biotech Trades for Second Half of 2011

(TheStreet) -- The biotech calendar for the second half of 2011 is filled with drug approval decisions and clinical trial outcomes, enough to keep biotech stocks jumping for the remainder of the year. Biotech investors crave tradeable events, but keeping track of clinical trials and Food and Drug Administration drug approvals can be a challenge. To make the job easier, I've compiled a list of 10 biotech stock trades for the second half of 2011.

.